Literature DB >> 2137748

QT prolongation on the electrocardiogram in diabetic autonomic neuropathy.

J B Chambers1, M J Sampson, D C Sprigings, G Jackson.   

Abstract

Patients with Type 1 diabetes and autonomic neuropathy have an increased risk of sudden death for which the mechanism remains obscure. Prolongation of the QT interval on the electrocardiogram may occur with sympathetic dysfunction and is also associated with ventricular arrhythmia and sudden death. We have therefore measured the QT interval in patients with Type 1 diabetes with normal, borderline, and definitely abnormal autonomic function tests and in non-diabetic control subjects. The maximum QT interval was measured on 12-lead electrocardiograms recorded at rest and then plotted against the RR interval. The QT interval was above the upper 95% limit for the non-diabetic control subjects in 5 diabetic patients with abnormal autonomic function tests (33%), but in no cases with normal or borderline tests. Multivariate analysis confirmed that autonomic score contributed significantly (p less than 0.025) to the variance in QT interval. The raw Valsalva ratio alone also contributed significantly to the variance in QT interval (p = 0.025). Heart rate variability, heart rate response to standing, age, sex, and the presence of symptoms of autonomic neuropathy did not contribute significantly.

Entities:  

Mesh:

Year:  1990        PMID: 2137748     DOI: 10.1111/j.1464-5491.1990.tb01342.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

1.  Diabetic autonomic neuropathy.

Authors:  R W Bilous
Journal:  BMJ       Date:  1990-09-22

2.  Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography.

Authors:  D Claus; H Feistel; C Brunhölzl; G Platsch; B Neundörfer; F Wolf
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

3.  Use of corrected QT interval in autonomic function testing: assessment of reproducibility.

Authors:  M Veglio; S Maule; C Matteoda; R Quadri; M Valentini; O Pecchio; G Piancino; L Chiandussi
Journal:  Clin Auton Res       Date:  1996-12       Impact factor: 4.435

Review 4.  Clinical observations and experiments in diabetic neuropathy.

Authors:  P J Watkins
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

5.  Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients.

Authors:  D J Ewing; O Boland; J M Neilson; C G Cho; B F Clarke
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

6.  The diabetic heart: A review of the lifework of Sophie Maria Koltai.

Authors:  Sophie M Koltai; Erzsébet Kocsis; Ildikó Pósa; Pál Hadházy; György Jermendy; Gábor Pogátsa
Journal:  Exp Clin Cardiol       Date:  2002

Review 7.  Diabetic autonomic neuropathy.

Authors:  M J Stevens; P J Watkins
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

8.  Effects of metoprolol on QT interval and QT dispersion in Type 1 diabetic patients with abnormal albuminuria.

Authors:  E Ebbehøj; H Arildsen; K W Hansen; C E Mogensen; H Mølgaard; P L Poulsen
Journal:  Diabetologia       Date:  2004-06-08       Impact factor: 10.122

9.  The relationship between QTc interval and cardiac autonomic neuropathy in diabetes mellitus.

Authors:  Ali Pourmoghaddas; Ali Hekmatnia
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

Review 10.  Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Authors:  Mónica Gallego; Julián Zayas-Arrabal; Amaia Alquiza; Beatriz Apellaniz; Oscar Casis
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.